Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
Shaw, A.N., Tedesco, R., Bambal, R., Chai, D., Concha, N.O., Darcy, M.G., Dhanak, D., Duffy, K.J., Fitch, D.M., Gates, A., Johnston, V.K., Keenan, R.M., Lin-Goerke, J., Liu, N., Sarisky, R.T., Wiggall, K.J., Zimmerman, M.N.(2009) Bioorg Med Chem Lett 19: 4350-4353
- PubMed: 19515564 
- DOI: https://doi.org/10.1016/j.bmcl.2009.05.091
- Primary Citation of Related Structures:  
3HHK - PubMed Abstract: 
The synthesis and optimisation of HCV NS5B polymerase inhibitors with improved potency versus the existing compound 1 is described. Substitution in the benzothiadiazine portion of the molecule, furnishing improvement in potency in the high protein Replicon assay, is highlighted, culminating in the discovery of 12h, a highly potent oxyacetamide derivative.
Organizational Affiliation: 
Department of Medicinal Chemistry, GlaxoSmithKline, Collegeville, PA 19426, USA.